Grants and Contributions:
Title:
Assessment of Safety and Efficacy for BryoBright: In Vitro Screening of a Novel Skincare Ingredient
Agreement Number:
1031563
Agreement Value:
$21,572.00
Agreement Date:
Jun 16, 2025 - Oct 31, 2025
Description:
The project will support in vitro screening of a moss-produced flavonoid for safety and efficacy.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V5N 2G2
Reference Number:
172-2025-2026-Q1-1031563
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
756706941
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days.
Amendment Date
Aug 6, 2025
Recipient's Operating Name:
Bryosphere
Recipient's Legal Name:
Bryosphere Biotechnologies Inc.
Federal Riding Name:
Vancouver East
Federal Riding Number:
59035
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171
Amendments: